weight loss center semaglutide Medicare expands availability for GLP-1 drugs. A KU doctor explains what to know | KCUR Miami Semaglutide/Tirzepatide Clinic Weight Loss

Key Takeaways: Most people experience mild nausea, low energy, or a shift in appetite in the first week

Research on GLP-1 receptor agonists like Ozempic and Wegovy concludes there is a risk for increased psychiatric symptoms

The process is not without its complexities, but with meticulous dosage adjustments, monitoring, and side effect management, it can lead to a seamless and successful changeover

These medications should be safe to take together if your doctor agrees its safe for you

Nawrocki or your physician

Symptom Reduction: Many patients report a reduction in the daily pain, heaviness, and swelling of their limbs, even if the volume of the legs hasn't changed drastically